Patten & Patten’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Patten & Patten’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-16,225	Closed	-$292K	–	245
2020 Q2	$292K	Sell	16,225 -2,100	-11%	-$29.2K	0.03%	204
2020 Q1	$131K	Sell	18,325 -21,700	-54%	-$271K	0.02%	221
2019 Q4	$956K	Buy	40,025 +6,325	+19%	+$174K	0.1%	137
2019 Q3	$904K	Buy	+33,700	New	+$946K	0.1%	135

Patten & Patten's PTLA Position: Q3 2020 in Review

Patten & Patten sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 16,225 shares — an estimated $292K sold.

Patten & Patten first reported a position in PTLA in Q3 2019 and held it in 4 quarters. The position peaked at $956K in Q4 2019. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

Patten & Patten reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Patten & Patten sold 16,225 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $292K.
Patten & Patten first reported a position in Portola Pharmaceuticals, Inc. in Q3 2019 and held it in 4 quarters.
Patten & Patten's Portola Pharmaceuticals, Inc. position peaked at $956K in Q4 2019.
0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Patten & Patten's 13F filing for Q3 2020, filed 8 Oct 2020.